[۶۸Ga]Ga-PSMA-۱۱ PET/CT for staging and patient management of high-risk prostate cancer: A single-center experience from Iran
- سال انتشار: 1401
- محل انتشار: مجله پزشکی هسته ای ایران، دوره: 30، شماره: 1
- کد COI اختصاصی: JR_IRJNM-30-1_005
- زبان مقاله: انگلیسی
- تعداد مشاهده: 442
نویسندگان
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Nuclear Medicine Department, Razavi Hospital, Imam Reza International University, Mashhad, Iran
Department of Radiation Oncology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
Introduction: Accurate staging plays an important role in management of patients with prostate cancer especially in high-risk group. Today, [۶۸Ga]Ga-PSMA-۱۱ PET/CT should be considered as the preferred imaging tool for treatment planning and initial staging of the disease. Methods: A total number of ۶۲۸ patients with prostate cancer referred to Razavi hospital nuclear medicine department between March ۲۰۱۶ and December ۲۰۱۹. Among ۱۰۳ patients in initial staging category, ۲۳ cases met our inclusion criteria and entered the study. All patients performed CT scan or MRI accompanied with bone scintigraphy before [۶۸Ga]Ga-PSMA-۱۱ PET/CT. The scan results were compared with conventional imaging and their treatment plan determined before and after performing[۶۸Ga]Ga-PSMA-۱۱ PET/CT. Results: The detection rate of [۶۸Ga]Ga-PSMA-۱۱ PET/CT was superior to CT/MRI in local lymph node involvements (۵۶.۵% to ۲۱.۷%), as well as for distant metastases (۴۷.۸۳% to ۱۳%). The scan findings lead to upstaging in ۹ patients and down staging in ۴ patients.[۶۸Ga]Ga-PSMA-۱۱ PET/CT results changes the therapeutic plan in ۱۳ patients (۵۶.۵%). Conclusion: [۶۸Ga]Ga-PSMA-۱۱ PET/CTis a promising imaging tool for initial staging of high-risk prostate cancer patients with significant higher detection rate in comparison to the conventional imaging. The study showed ۵۶.۵% changes in treatment planning following [۶۸Ga]Ga-PSMA-۱۱ PET/CT study.کلیدواژه ها
[۶۸Ga]Ga-PSMA-۱۱, PET/CT, prostate cancer, High risk, Stagingاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.